510(k) Report

510(k) · Cleared

Cleared

Elecsys CK-MB Stat

K974421510(k) TraditionalCleared Dec 17, 199723-day reviewClass II21 CFR 862.1215

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Boehringer Mannheim Corp. · JHY Colorimetric Method, Cpk Or Isoenzymes

Cleared on Dec 17, 1997 as substantially equivalent to K961501 (Boehringer Mannheim Corp., 1996) after a 23-day review. Its family tree reaches back 2 generations to 1993. 3 later devices descend from it.

Decided
Dec 17, 1997
Review
23 days
Class
Class II
Product code
JHY
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K931172 (1993). 3 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2002: 1 descendant cleared2013: 1 descendant cleared2014: 1 descendant clearedK931172 · Imx (R) Stat CK-MB · Abbott Laboratories · 1993K961501 · Elecsys CK-MB · Boehringer Mannheim Corp. · 19961990200020102020
Descendants, by generation 1 generation forward: 1 descendant2 generations forward: 1 descendant3 generations forward: 1 descendant K961501 · Elecsys CK-MB · Boehringer Mannheim Corp. · 1996K931172 · Imx (R) Stat CK-MB · Abbott Laboratories · 19930
  1. Root · 2 generations backK931172 Imx (R) Stat CK-MBAbbott Laboratories · 1993
  2. 1 generation backK961501 Elecsys CK-MBBoehringer Mannheim Corp. · 1996
  3. This deviceK974421 Elecsys CK-MB StatBoehringer Mannheim Corp. · 1997
  4. Descendant · cites it directly · 2 of its ownK022654 Modification to Elecsys CK-MB Stat, Elecsys CK-MBRoche Diagnostics Corp. · 2002
  5. Descendant · 2 generations on · 1 of its ownK132571 Elecsys CK-MB Stat Immunoassay, Elecsys CK-MB ImmunoassayRoche Diagnostics · 2013
  6. Descendant · 3 generations on · 0 of its ownK140404 Elecsys CK-MB Stat ImmunoassayRoche Diagnostics · 2014

Most influential descendants

Showing 3 of 3 · See all
  • K022654Modification to Elecsys CK-MB Stat, Elecsys CK-MBRoche Diagnostics Corp. · 2002 · cites it directly2descendants
  • K132571Elecsys CK-MB Stat Immunoassay, Elecsys CK-MB ImmunoassayRoche Diagnostics · 2013 · 2 generations on1descendant
  • K140404Elecsys CK-MB Stat ImmunoassayRoche Diagnostics · 2014 · 3 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K931172Imx (R) Stat CK-MBAbbott Laboratories1993—
−1K961501Elecsys CK-MBBoehringer Mannheim Corp.1996—
0 (this device)K974421Elecsys CK-MB StatBoehringer Mannheim Corp.1997—
+1K022654Modification to Elecsys CK-MB Stat, Elecsys CK-MBRoche Diagnostics Corp.2002—
+2K132571Elecsys CK-MB Stat Immunoassay, Elecsys CK-MB ImmunoassayRoche Diagnostics2013—
+3K140404Elecsys CK-MB Stat ImmunoassayRoche Diagnostics2014—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200210
201310
201410
FIG. 1 — Lineage of K974421, 1993–2014Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JHY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K961501Elecsys CK-MB
Summary page 1
…al distribution intended for similar use. Most notably it is substantially equivalent to the currently marketed first generation Boehringer Mannheim Elecsys CK-MB STAT (K961501). Continued on next page UAQA_QQCWQA\RA\Elecsys\S 10(k)'s\CK-MB\CK-MB 510k FDA.doc 25 Boehringer Mannheim Corpo…
Boehringer Mannheim Corp.1996—

Also cleared against K961501: 1 other device →

What descends from it? (3)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K022654Modification to Elecsys CK-MB Stat, Elecsys CK-MBRoche Diagnostics Corp.20022

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 4 years and passes through 2 companies; a new generation was cleared every 3.0 years on median.
  • None of the 2 ancestors has a recall.
  • Of its descendants, K022654 (Roche Diagnostics Corp., 2002) has gone furthest, with 2 descendants of its own.
  • 1 other device also cites its predicate K961501.

How does its category compare?

All JHY devices

JHY Colorimetric Method, Cpk Or Isoenzymes: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · JHY

1in 2015

2007: 12013: 12014: 22015: 1
2007high 2 (2014) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JHY

Too few JHY 510(k)s in any year since 2007 to give a median.

Recalls per year · JHY

1in 2010

2010: 1
2007high 1 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JHY

3in 2023

2012: 12014: 32015: 22016: 42017: 112018: 52019: 22020: 22022: 12023: 3
2007high 11 (2017) · low 0 (2007)2025

MAUDE reports naming product code JHY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20080—00
20090—00
20100—10
20110—00
20120—01
20131—00
20142—03
20151—02
20160—04
20170—011
20180—05
20190—02
20200—02
20210—00
20220—01
20230—03
20240—00
20250—00
20260—0—

What is it indicated for?

Immunoassay for the in vitro quantitative determination of the MB isoenzyme of creatine kinase (CK-MB) in human serum and plasma.

A creatine phosphokinase / creatine kinase or isoenzymes test system is a device intended to measure the activity of the enzyme creatine phosphokinase or its isoenzymes (a group of enzymes with similar biological activity) in plasma and serum. Measurements of creatine kinase and its isoenzymes are used in the diagnosis and treatment of myocardial infarction and muscle diseases such as progressive, Duchenne-type muscular dystrophy.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K974421: Elecsys CK-MB Stat.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K974421

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026